Alzamend Neuro Inc
Biotechnology
Healthcare
ALZN
779 K shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.37
52 week high
5.44
high
2.46
52 week low
0.00
low
2.33
growth
-30.88 %
previous Close
2.37
P/E ratio
-2
market cap
7.54 M
div yield
0
usd
Jul 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
-1.28 %
86.50 %
eps surprise
-85.51 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top